Paweł Wiśniewski, PhD

About

Dr. Wiśniewski has over fifteen years of experience in biotech business development, drug discovery and technical due diligence, which he gained holding the position of: - Founder and CEO at Instytut Analiz Genetycznych Sp. z o.o. (Inagen), a Polish biotech company developing advanced molecular profiling for sports entities and individual athletes - Founder CEO at 4Cell Therapies S.A., a Polish biotech company developing innovative CAR-T therapies - Associate Member of the Management Board at Helix BioPharma, a publicly listed, Canadian biotech company - Vice-Chairman of the Supervisory Board at Pure Biologics S.A., a publicly listed, Polish biotech company - Member of the Supervisory Board at Orphinic Scientific S.A., a biopharma holding investing in prospective biotech companies worldwide

Experience

• Member of The Medical Team, Polish Football Association Technical Committee at PZPN (Polski Związek Piłki Nożnej)
  Nov 2025 - Present · 9 mos

• Member of The Supervisory Board at Orphinic Scientific
  Sep 2023 - Present · 2 yrs 11 mos

• Vice Chairman of The Supervisory Board at Pure Biologics
  May 2023 - Present · 3 yrs 3 mos

• CEO at Inagen
  Apr 2011 - Present · 15 yrs 4 mos

  Poland-based company focused on the genomic data analysis to support building elite teams in professional sports entities. Talent identification, injury prevention and training program tailoring.

• CEO at 4Cell Therapies
  2015 - Present · 11 yrs 7 mos

  A Polish company focused on the development of innovative immunotherapies based on monoclonal antibodies, antibody-drug conjugates and adoptive T-cell transfer.